Diaceutics PLC Stock: price and insider trades · United Kingdom
No insider purchase over the last 90 days. The latest, by Graham Patterson, was filed 07 Mar 2024.
Diaceutics PLC: what insiders have been doing
We have very little insider data for Diaceutics PLC so far: the most recent filing dates from 7 March 2024. With so few records, no pattern can be drawn yet. These figures are compiled from regulatory filings published by RNS (LSE). They describe what insiders did and are not a recommendation.
Analyst consensus: bullish or bearish?
Analysts rate Diaceutics PLC Strong Buy (bullish), based on 5 analysts. Average price target: £2.13.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 33,564 shares@ £0.985100.0% of flowAIM Market of the London Stock ExchangeISIN GB00BJQTGV64RNS:5095176Canonical exit: 4 Jun 2024 (T+90)
1 of 1 declaration
About Diaceutics PLC
Diaceutics PLC is a company specializing in health data analytics, aiming to improve patient outcomes through personalized treatments. It primarily operates in the UK market and focuses on optimizing diagnostic testing.
